Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

Neuropeptide FF Receptor 1 Antibodies

Close filters
No results were found for the filter!
NEW
Agonist-induced Serine385/Serine387 phosphorylation of the Neuropeptide Receptor 1
pS385/pS387-NPFF1 (phospho-Neuropeptide FF...
Serine385/Serine387 (S385/S387) is major phosphorylation site of the Neuropeptide FF Receptor 1 (NPFF1). The pS385/pS387-NPFF1 antibody detects phosphorylation in response to agonists. S385/S387 phosphorylation is likely to be involved...
$ 350.00 *
Details
NEW
Agonist-induced Serine361 phosphorylation of the Neuropeptide FF Receptor 1
pS361-NPFF1 (phospho-Neuropeptide FF Receptor 1...
Serine361 (S361) is major phosphorylation site of the Neuropeptide FF Receptor 1 (NPFF1). The pS361-NPFF1 antibody detects phosphorylation in response to agonists. S361 phosphorylation is likely to be involved in efficient ligand...
$ 350.00 *
Details

NPFF1

NPFF1 is expressed in various brain regions including the limbic system of telencephalon, diencephalon, mesencephalon and pituitary where NPFF1 could participate in neuroendocrine functions. NPFF1 couples with Gαi to inhibit adenylyl cyclase. NPFF1 receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal serine361 (pS361-NPFF1) and serine385/serine387 (pS385/pS387-NPFF1). This nomenclature refers to the human NPFF1 receptor. This phosphorylation motif is conserved across species and corresponds to pS363-NPFF1 and pS387/pS389-NPFF1 in rats. For more information on NPFF1 pharmacology please refer to the IUPHAR database. For further reading refer to:

Mollereau-Manaute C, Moulédous L, Roumy M, Tsutsui K, Ubuka T, Zajac JM. Neuropeptide FF/neuropeptide AF receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019; 2019(4). Available from: https://doi.org/10.2218/gtopdb/F43/2019.4.

NPFF1 is expressed in various brain regions including the limbic system of telencephalon, diencephalon, mesencephalon and pituitary where NPFF1 could participate in neuroendocrine functions.... read more »
Close window
Neuropeptide FF Receptor 1 Antibodies

NPFF1

NPFF1 is expressed in various brain regions including the limbic system of telencephalon, diencephalon, mesencephalon and pituitary where NPFF1 could participate in neuroendocrine functions. NPFF1 couples with Gαi to inhibit adenylyl cyclase. NPFF1 receptor desensitization, β-arrestin recruitment and internalization are regulated by phosphorylation of carboxyl-terminal serine361 (pS361-NPFF1) and serine385/serine387 (pS385/pS387-NPFF1). This nomenclature refers to the human NPFF1 receptor. This phosphorylation motif is conserved across species and corresponds to pS363-NPFF1 and pS387/pS389-NPFF1 in rats. For more information on NPFF1 pharmacology please refer to the IUPHAR database. For further reading refer to:

Mollereau-Manaute C, Moulédous L, Roumy M, Tsutsui K, Ubuka T, Zajac JM. Neuropeptide FF/neuropeptide AF receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019; 2019(4). Available from: https://doi.org/10.2218/gtopdb/F43/2019.4.

Recently viewed